Source: Agency for Science, Technology and Research (A*STAR), Singapore
Date: November 21, 2008
Summary:
Researchers from the Institute of Medical Biology (IMB) under the Agency for Science, Technology and Research (A*STAR) and the Yong Loo Lin School of Medicine (YLLSoM ) at the National University of Singapore (NUS) have scored a breakthrough in developing an unlimited number of pure insulin-producing cells from mouse embryonic stem cells (ESCs)[1]. The cells, which have the same sub-cellular structures as the insulin-producing cells naturally found in the pancreas, were highly effective in treating diabetes in the mouse model.
